◆ 会议时间：2026年8月26-29日
◆ 会议地点：澳大利亚 布里斯班
◆ 会议简介：
2026年第8届国际头颈肿瘤学会联盟(IFHNOS)世界大会将于2026年8月26-29日在澳大利亚布里斯班举行。
国际头颈肿瘤学会联盟(IFHNOS)由美国纪念斯隆-凯特琳癌症中心(MSKCC)头颈外科主任Jatin P. Shah于1987年组织建立，现已发展成为一个代表全球65个国家和区域的53个头颈肿瘤专业组织成员的全球性组织。IFHNOS的宗旨是为从事头颈部癌症领域的专家提供一个互动的平台，加强信息交流，提高知识，探索头颈癌患者诊断、治疗和康复的新方向。IFHNOS自1997年开始每4年举办一次世界大会。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）.
IFHNOS 2026 -
8th World Congress of the International Federation of Head and Neck Oncologic Societies
Date:
26 – 29 August 2026
Venue:
Brisbane Convention and Exhibition Centre
Brisbane, Australia
The theme of the congress is “Global Harmonisation of Head and Neck Cancer Care”.
摘要征文投稿：
- Abstract Submission Deadline - extended until 11:59pm AEST, Sunday 26 April 2026
- Notifications to Authors - May 2026
- Early Bird Registration Ends - 11:59pm AEST, Sunday 19 April 2026
点此提交摘要>>>Submit Abstract>>>
点此查看更多摘要相信息>>>
PAPER TYPES
The IFHNOS World Congress 2026 is accepting abstracts for the below categories. You must indicate the paper type when submitting online.
- Verbal presentation
- e-Poster
TOPICS
The IFHNOS World Congress 2026 Organising Committee requests authors to submit abstracts in the following topics:
SITES:
- Hypopharynx
- Larynx
- Nasopharynx
- Oral Cavity
- Oropharynx
- Oropharynx (HPV associated)
- Salivary Gland
- Skin (non-melanomatous)
- Skull base/Paranasal Sinus/Perineural Disease
- Thyroid
- Unknown Primary
SPECIFIC HISTOLOGIES:
- Adenoid cystic
- Melanoma
- Merkel cell carcinoma
- Premalignant
- Other
SUBSPECIALTY/TREATMENT SPECIFIC:
- Dental, Oral Medicine and Prosthetics
- Dietetics
- Head and Neck Surgery
- Maxillofacial Surgery
- Medical Oncology
- Nursing
- Pathology
- Physiotherapy
- Plastics/Reconstructive Surgery
- Radiation Oncology
- Radiology
- Robotics
- Speech Pathology
DIGITAL ADVANCEMENTS:
- Artificial Intelligence
- Databases
- Digital Technologies
LABORATORY:
- Discovery Science
- Translational Research incl Biomarkers
PREVENTION/SURVIVORSHIP/QOL:
- Health Services Research/Health care delivery
- Pre and Post Rehabilitation
- Prevention
- Surveillance
- Survivorship/Quality of Life
- Treatment toxicity (physical/financial)
OTHER
SUBMISSION GUIDELINES
1. Authors of research papers who wish to have their abstracts considered for inclusion must submit their abstract electronically via the congress website having regard to the published closing date. Abstracts submitted after the closing date will not be considered.
2. The title should be brief and explicit.
3. Research papers should follow the format – Aims, Methodology, Results, Conclusion.
4. Excluding title, authors (full given first name and family name) and institution, the abstract must not exceed 2,000 characters and spaces (approximately 300 words). In MS Word, this count can be determined from the ‘Review menu’. Any references must be included in this allowance. If you exceed this limit, the excess limit will NOT appear in the meeting publication.
5. Include details of main institution only.
6. Abbreviations should be used only in common terms. For uncommon terms, the abbreviation should be given in brackets after the first full use of the word.
7. Presentations (slide and video) will only have electronic PowerPoint support. Audio visual instructions will be provided to all successful authors.
8. A 50-word CV is required from each presenter to facilitate the Chair’s introduction. Excess text will not be captured by the system.
9. The acceptance, timing, presentation and discussion of all papers and posters are at the discretion of the Organising Committee. Notification of the timing of presentations will appear in correspondence sent to all successful authors.
10. Tables, diagrams, graphs etc. CANNOT be accepted in the abstract submission. This is due to the limitations of the computer software program.
11. Please do not type your abstract directly into the submission page. Being internet based, each page on the submission site can only be open for 15 minutes before closing. Type your submission on a text document (eg. MS Word) and copy and paste it into the abstract text field.
12. AUTHORS MUST BE REGISTRANTS OF THE CONGRESS TO PRESENT AND FOR THEIR ABSTRACT TO APPEAR IN THE PUBLICATIONS.
13. Authors are required to declare conflict of interest if applicable. Failure or refusal to disclose or the inability to resolve the identified conflict will result in the abstract acceptance being withdrawn.
14. Amendments to abstracts after submission are not guaranteed.
Important Note: The submitting author of an abstract will ALWAYS receive an email confirmation of receipt of the abstract into the submission site. If you do not receive a confirmation email within 24 hours, it may mean the abstract has not been received. In this circumstance, please email ifhnos@surgeons.org to determine why a confirmation email was not received.
Dear Colleagues,
The 8th IFHNOS World Congress will be held in Brisbane, Australia, in August 2026, in collaboration with the Australian and New Zealand Head and Neck Cancer Society. The Congress will be centered around the theme "Global Harmonization of Head and Neck Cancer Care through international collaboration."
Brisbane city and the Southbank precinct, the site of the conference venue, is an ideal location for a meeting. Brisbane has a relaxed subtropical feel, while at the same time it has all the facilities, restaurants and entertainment venues that will make it a memorable experience for delegates, accompanying partners and families.
There is a real vibrancy to the city as it prepares to host the 2032 Summer Olympic Games and is the gateway to many of the places people love to visit when in Australia such as the Gold Coast and Great Barrier Reef.
IFHNOS is made up of over 70 member societies across 58 countries, and so this will truly be an engaging international head and neck cancer conference for the ages. Along with the organising team, we plan to deliver an exciting 3 days of a high quality scientific and social program.
I do hope you can join us and contribute to what I anticipate will be one of the most successful IFHNOS meetings of all time. I look forward to welcoming you to Australia.
Sandro V Porceddu
Convener
IFHNOS 8th World Congress 2026
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
